申请人:Warner-Lambert Company
公开号:US06323243B1
公开(公告)日:2001-11-27
The present invention provides compounds that block calcium channels and have the Formula I:
and pharmaceutically acceptable salts, esters, and pro-drugs thereof, wherein
R1 and R2 are independently H, phenylcyclopentylcarbonyl, C1-C7 alkyl, cyclohexylmethyl, benzyl, C1-C5 alkylbenzyl, or C1-C5 alkoxybenzyl,
A is —C(O)— or —CH2—;
R3 is H or —CH3;
R4 is C1-C4 alkyl or piperidin-1-ylethyl;
R5 is phenyl-(CH2)n—, C1-C4 alkylphenyl-(CH2)n—, or halophenyl-(CH2)n—; and
n is 1 or 2.
The present invention also provides pharmaceutical compositions containing the compounds of Formula I and methods of using them to treat stroke, cerebral ischemia, head trauma, and epilepsy.
本发明提供了阻断钙通道的化合物,其具有公式I:以及其药学上可接受的盐,酯和前药,其中R1和R2独立地是H,苯基环戊基甲酰基,C1-C7烷基,环己基甲基,苄基,C1-C5烷基苄基或C1-C5烷氧基苄基,A是—C(O)—或—CH2—; R3是H或—CH3; R4是C1-C4烷基或哌啶-1-乙基; R5是苯基-(CH2)n—,C1-C4烷基苯基-(CH2)n—或卤代苯基-(CH2)n—; n为1或2。本发明还提供了含有公式I化合物的药物组合物以及使用它们治疗中风,脑缺血,头部创伤和癫痫的方法。